相关实验视频

Updated: Mar 7, 2026

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

激酶LRRK2介导剂增加了微质中的GCase活性,以应对IFNγ诱导的炎症前刺激

Emma J MacDougall¹, Carol X-Q Chen², Eric Deneault^2,3

¹Neurodegenerative Disorders Research Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital (The Neuro), McGill University, Montreal, QC, Canada.

NPJ Parkinson's disease

|March 5, 2026

概括

帕金森病 (PD) 风险基因LRRK2和GBA1影响葡萄糖大脑酶 (GCase) 活性. LRRK2激酶活性调节GCase水平,特别是在神经炎症期间,这表明PD病变发生过程中存在复杂的相互作用.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
生物化学生物化学

背景情况:

LRRK2和GBA1变种是帕金森病 (PD) 的常见风险因素.
在患有GBA1变异的PD患者和一些零星的PD病例中观察到降低的葡萄糖大脑酶 (GCase) 活性.
LRRK2变异对GCase活性的影响是有争议的,在不同细胞类型的数据中存在矛盾.

研究的目的:

研究LRRK2激酶活性对人类诱导多能干细胞 (iPSC) 衍生微质细胞 (iMG) 中的GCase活性的影响.
探索LRRK2和GBA1之间的相互作用,在帕金森病的病原性背景下.

主要方法:

使用CRISPR编辑生成同源控制iPSC线路,以匹配PD患者衍生的iPSC线路与LRRK2变体 (p.G2019S,p.M1646T,p.N551K-p.R1398H保护性单元型).
评估了LRRK2基质酸化 (Rab10),GCase蛋白水平,以及IMG中的GCase活性.
利用LRRK2的药理抑制和干扰素玛 (IFNγ) 刺激来评估GCase活性调节.

主要成果:

LRRK2变体p.M1646T和保护性哈普洛型改变了Rab10的酸化,但没有影响GCase蛋白水平或IMG中的活性.
药理上LRRK2抑制没有影响基底GCase活性,但减弱了IFNγ诱导的GCase活性.
IFNγ诱导的GCase活性被LRRK2变体调节,显示p.M1646T iMGs中的活性降低,p.N551K-p.R1398H iMGs中的活性增加.

结论:

LRRK2激酶活性在调节GCase活性方面发挥作用,特别是在对IFNγ等神经炎症刺激的反应中.
这些发现表明,在帕金森病中,LRRK2和GBA1通路之间存在复杂的相互作用.
这些结果为与LRRK2和GBA1遗传学相关的帕金森病背后的分子机制提供了新的见解.

更多相关视频

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

Assaying the Kinase Activity of LRRK2 in vitro

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

相关概念视频

Regulation of the Unfolded Protein Response

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...